# Resistentia Pharmaceuticals

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/resistentia-pharmaceuticals

- Industry: Biotechnology
- Headquarters: Uppsala, Sweden
- Total disclosed funding: $14M
- Latest round: Series C (Sep 26, 2006)
- Investors on record: 5

## About

Resistentia Pharmaceuticals, is based in Sweden and is a biopharmaceutical company, develops immunotherapeutic products for allergic asthma and inflammatory disorders.

## Funding rounds

- Series C, Sep 26, 2006, $14M — InnovationsKapital, HealthCap, Industrifonden, GlaxoSmithKline, BankInvest

## Investors

- InnovationsKapital (https://capitalatlas.ai/funds/innovationskapital) — Series C
- HealthCap — Series C
- Industrifonden (https://capitalatlas.ai/funds/industrifonden) — Series C
- GlaxoSmithKline — Series C
- BankInvest (https://capitalatlas.ai/funds/bankinvest) — Series C